Ergebnisse einschränken

Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma

Strobel, K. ; Bode, B. ; Dummer, R. ; Veit-Haibach, P. ; Fischer, D. ; Imhof, L. ; Goldinger, S. ; Steinert, Hans ; von Schulthess, G.

In: European Journal of Nuclear Medicine and Molecular Imaging, 2009, vol. 36, no. 11, p. 1774-1782

SPECT/CT in der Handgelenkdiagnostik = SPECT/CT in diagnostics of the hand joint

Huellner, M.W. ; Strobel, K. ; Hug, U. ; von Wartburg, U. ; Veit-Haibach, P.

The additional value of CT images interpretation in the differential diagnosis of benign vs. malignant primary bone lesions with 18F-FDG-PET/CT

Strobel, K. ; Exner, U. ; Stumpe, K. ; Hany, T. ; Bode, B. ; Mende, K. ; Veit-Haibach, P. ; von Schulthess, G. ; Hodler, Juerg

In: European Journal of Nuclear Medicine and Molecular Imaging, 2008, vol. 35, no. 11, p. 2000-2008

Chemotherapy response assessment in stage IV melanoma patients—comparison of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B

Strobel, Klaus ; Dummer, Reinhard ; Steinert, Hans ; Conzett, Katrin ; Schad, Karin ; Lago, Marisol ; Soyka, Jan ; Veit-Haibach, P. ; Seifert, Burkhardt ; Kalff, V.

In: European Journal of Nuclear Medicine and Molecular Imaging, 2008, vol. 35, no. 10, p. 1786-1795

Hodgkin's lymphoma in remission after first-line therapy: which patients need FDG-PET/CT for follow-up?

Petrausch, U. ; Samaras, P. ; Veit-Haibach, P. ; Tschopp, A. ; Soyka, J. D. ; Knuth, A. ; Hany, T. F. ; Mischo, A. ; Renner, C. ; Schaefer, N. G.

In: Annals of Oncology, 2010, vol. 21, no. 5, p. 1053-1057

Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy

Petrausch, U. ; Samaras, P. ; Haile, S. R. ; Veit-Haibach, P. ; Soyka, J. D. ; Knuth, A. ; Hany, T. F. ; Mischo, A. ; Renner, C. ; Schäefer, N. G.

In: Annals of Oncology, 2010, vol. 21, no. 8, p. 1694-1698

Feasibility of low-dose coronary CT angiography: first experience with prospective ECG-gating

Husmann, L.

In: European Heart Journal, 2008, vol. 29, no. 2, p. 191-197

Cost-effective therapy remission assessment in lymphoma patients using 2-[fluorine-18]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography: is an end of treatment exam necessary in all patients?

Strobel, K. ; Schaefer, NG ; Renner, C. ; Veit-Haibach, P. ; Husarik, D. ; Koma, AY ; Hany, TF

In: Annals of Oncology, 2007, vol. 18, no. 4, p. 658-664